GILEAD SCIENCES, INC.

Holdings History for Xilio Therapeutics, Inc. - Common Stock, par value $0.0001 per share (XLO)

Symbol: XLO on Nasdaq
Investment type: Equity - Shares of Stock
Class: Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 9.11M shares
Security Ownership: 19.9%

Shares, Excluding Options vs Price

Value, Excluding Options

GILEAD SCIENCES INC ownership in Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO)

2024-12-19 - GILEAD SCIENCES INC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 9.11M shares of Xilio Therapeutics, Inc. Common Stock, par value $0.0001 per share (XLO). This represents 19.9% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
GILEAD SCIENCES INC	19.9%		$6.6M	9.11M			$0.72	13G/A	12/18/2024	19 Dec 2024 16:15:45

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
12/31/2024		0.56%		$8.7M	9.11M			$0.96	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.